CIGNITITEC vs EXPLEOSOL: Stock Comparison
CIGNITITEC is the larger company by market capitalisation. CIGNITITEC shows a higher ROE, faster revenue growth and a higher ROCE, while EXPLEO SOLUTIONS shows a lower P/E, a higher dividend yield and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
CIGNITITEC leads 8; EXPLEOSOL leads 4 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | CIGNITITEC | EXPLEOSOL |
|---|---|---|
| Sector | Information Technology | Information Technology |
| Industry | IT Enabled Services | IT Enabled Services |
Price
| Metric | CIGNITITEC | EXPLEOSOL |
|---|---|---|
| Live Price | ₹1,260.3 | ₹889.5 |
| Day Change | -2.13% | 0.64% |
| Volume | 1.57 L | 9,546 |
| 52-Week High | ₹1,929.5 | ₹1,175.1 |
| 52-Week Low | ₹996.5 | ₹640 |
| Distance from 52W High | -34.68% | -24.3% |
Valuation
| Metric | CIGNITITEC | EXPLEOSOL |
|---|---|---|
| Market Cap | ₹3,485 Cr | ₹1,383 Cr |
| P/E Ratio | 11.5x | 10.02x |
| P/B Ratio | 3.07x | 1.78x |
| EPS | ₹29.15 | ₹18.78 |
| Book Value | ₹349.67 | ₹500.21 |
| Dividend Yield | 0% | 12.34% |
Growth
| Metric | CIGNITITEC | EXPLEOSOL |
|---|---|---|
| Revenue Growth (TTM YoY) | 14% | 11.9% |
| EPS Growth (TTM YoY) | 94.35% | 73.2% |
| Qtr Sales Growth | 47.51% | -12.31% |
| Qtr Profit Growth | 49.26% | -14.75% |
Profitability & Leverage
| Metric | CIGNITITEC | EXPLEOSOL |
|---|---|---|
| ROE | 30.75% | 15.97% |
| ROCE | 35.38% | 31.98% |
| Net Margin | 9.94% | 11.19% |
| Operating Margin | 21% | 14.87% |
| Debt to Equity | 0x | 0x |
Shareholding
As of Mar 2026 • change vs previous quarter| Metric | CIGNITITEC | EXPLEOSOL |
|---|---|---|
| Promoter Holding | 54% | 71.05% |
| FII Holding | 10.43%▼ 1.17 pp | 0.13%▼ 0.29 pp |
| DII Holding | 11.58%▲ 2.27 pp | 0.12%▲ 0.11 pp |
| Public Holding | 23.99%▼ 1.11 pp | 28.7%▲ 0.17 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: CIGNITITEC and EXPLEO SOLUTIONS.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.